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methods available for blood melatonin include
enzyme immunoassay (EIA) [11], radioim-
munoassay (RIA) [12], GC–MS methods [13,14],
HPLC with fluorescence detection [15,16], and
HPLC with electrochemical detection [17], etc.
Although EIA and RIA were very sensitive for
the determination of melatonin in blood, some
anticoagulants and endogenous interfering com-
pounds may affect their specificity [11,12]. The
other chromatography-based methods [13–15,17]
require prior sample preparations (e.g. liquid– liq-
uid extraction or solid-phase extraction) to re-
move serum proteins and interfering compounds,
which are usually time-consuming and laborious.
In case of GC–MS methods [13,14], derivatiza-
tion of melatonin is needed prior to the analysis.
The purpose of this work is to develop a rapid,
sensitive and specific analytical method for the
quantitative determination of serum melatonin by
ESI–MS–MS with direct sample injection, which
employs an on-line sample extraction procedure.
Experimental
Chemicals and solutions
Melatonin (N-acetyl-5-methoxytryptamine) and
N-acetyltryptamine (internal standard) were ob-
tained from Sigma (St Louis, MO, USA). Ammo-
nium formate, formic acid, HPLC grade water
and acetonitrile were from Aldrich (Milwaukee,
WI, USA). Human sera (cat. number S7023, lot
number 120K8972) was purchased from Sigma
and kept at −20 °C.
A stock solution of ammonium formate (50
mM, pH 4.0) was prepared by dissolving appro-
priate amounts of ammonium formate in a known
volume of HPLC grade water. The pH of the
solution was adjusted to the desired value with
formic acid. Five mM ammonium formate at pH
4.0 was prepared by 1:10 dilution of the stock
solution with HPLC grade water.
Stock solutions (1.00 mg/ml) of melatonin and
N-acetyltryptamine (0.500 mg/ml, internal stan-
dard) were prepared by dissolving appropriate
amounts of each compound in a known volume
of methanol, which were stored at −20 °C when
not used.
Working standard solutions of melatonin (8.00,
80.0, 600 and 1000 ng/ml) and N-acetyl-
tryptamine (8.00, 80.0, 200 and 600 ng/ml) were
prepared by serial dilution of the stock solutions
with 5 mM ammonium formate (pH 4.0).
Blank sera, serum standards and samples
Human sera contained no detectable melatonin
were used as the blank sera. Serum standards
(0.500, 1.00, 2.00, 5.00, 15.0, 50.0, 100 and 200
ng/ml) were prepared by the serial dilution of the
1000-ng/ml melatonin working standard solution
with the blank sera.
Prior to the analysis, 10-l internal standard
solution (N-acetyltryptamine, 200 ng/ml in 5 mM
ammonium formate at pH 4.0) was added to
200-l serum standards and serum samples. The
mixtures were diluted with 190-l, 5 mM ammo-
nium formate (pH 4.0). After vortex mixing, these
solutions were transferred to autosampler vials for
instrument analysis.
Instrumentation
The instrumentation system used for this work
consisted of an HP1100 pump (Hewlett-Packard,
Palo Alto, CA, USA), an HP1100 autosampler, a
stainless steel in-line filter (0.5-m pore, 0.23-l
dead volume, Upchurch Scientific, Oak Harbor,
Fig. 1. Molecular structure of melatonin and the internal
standard, N-acetyltryptamine.
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Full scan spectra were acquired in the contin-
uum mode over the mass range of 180–280 u at
the scan rate of 500 u/s. Selected ion recording
(SIR) data were acquired by sequentially monitor-
ing quasi-molecular ions of the analytes ([mela-
tonin+H]+ at m/z 233 and [N-acetyltryp-
tamine+H]+ at m/z 203) with a span of 0.05 u, a
dwell time of 0.5 s, and an inter-scan delay of 0.03
s. Ionization parameters were the same as those
described above.
Multiple reaction monitoring (MRM) data
were acquired with the following parameters: m/z
233174 for melatonin, m/z 203144 for N-
acetyltryptamine, argon collision gas at 1.0 bar,
cone at 25 V, collision energy at 15 eV for each
analyte, low- and high-mass resolution at 15 for
both quadrupole 1 and 3, dwell time of 0.5 s, and
inter-scan delay of 0.03 s. The ionization parame-
ters used for MRM were the same as those for
SIR.
Quantitation
Data acqusition was done by MICROMASS
MASSLYNX software (Version 3.4). The peak area
ratios of melatonin to the internal standard (Y-
axis values) were plotted against the melatonin
concentrations (X-axis values) for the regression
equation. The serum melatonin concentration of
the unknown sample was determined by the re-
gression equation after obtaining the peak area
ratio of the unknown to the internal standard
from the mass chromatograms.
Recoery
The three-concentration-level (2.00, 20.0 and
150 ng/ml) serum samples used in the recovery
studies were prepared by adding 50-l internal
standard (N-acetyltryptamine, at 8.00, 80.0 and
600 ng/ml in 5 mM ammonium formate at pH
4.0), 50-l melatonin (at 8.00, 80.0 and 600 ng/ml
in 5 mM ammonium formate at pH 4.0), and
100-l of 5 mM ammonium formate (pH 4.0) to
200-l blank serum. The control samples were
prepared in 5 mM ammonium formate (pH 4.0) at
the same concentration levels. The recoveries of
melatonin and N-acetyltryptamine in human sera
were determined by comparing the mean peak
areas of serum samples to the mean peak areas of
the control samples.
Results and discussions
On-line sample preparation
Sample preparation is the bottleneck of most of
drug analyses in biological fluids. Direct sample
injection with on-line sample preparation has
been developed to simplify and expedite the ana-
lytical procedure for drug analyses. In this work,
Waters Oasis®HLB extraction cartridge was used
as an on-line column for the extraction of serum
melatonin and N-acetyltryptamine (internal stan-
dard). According to the manufacturer, the pack-
ing material of the extraction column is a
macroporous copolymer [poly(divinylbenzene-co-
N-vinylpyrrolidone)] and HLB is an acronym for
hydrophillic lipophillic balance which describes
the dual retention capability of the packing mate-
rial to retain polar and nonpolar compounds. The
water wettable polymeric sorbent of Oasis®HLB
allows the exclusion of proteins and other inter-
fering matrix constituents, and the retention of
acids, bases and neutral compounds with high and
reproducible recoveries [18].
By the experiments shown in Fig. 3, it was
found that serum proteins and other interfering
matrix constituents were completely eluted in less
than 1 min after sample injection using 5 mM
ammonium formate (pH 4.0) at the flow rate of
1.0 ml/min as the extraction buffer (Fig. 3A).
Meanwhile, melatonin, N-acetyltryptamine and
other endogenous compounds were retained on
the column even after 9-min washing with the
extraction buffer (Fig. 3B). Therefore, 2-min after
sample injection was chosen as the switching time
when the switching valve was turned from the
position 1 to 2 (Fig. 2). The elution of melatonin
and N-acetyltryptamine as well as other endoge-
nous compounds took place after the extraction
buffer was changed to the elution buffer (95%
CH3CN+5% 5 mM ammonium formate at pH
4.0) at 2 min of the sample injection. Fig. 3C and
D showed that these compounds reached the UV
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Table 2
Recoveries of melatonin and N-acetyltryptamine (I.S.) from human sera
20.0 ng/ml 150 ng/mlCompoundsa 2.00 ng/ml
CV (%) Recovery (%)Recovery (%) CV (%) Recovery (%) CV (%)
5.1 68.9 3.6 70.5 1.9Melatonin 69.1
1.7 53.2 4.559.1 57.7I.S. 0.67
Recovery=Mean peak area of serum samples (n=3)/Mean peak area of control samples (n=3)×100%.
a Injection volume=10 l.
Sodium adducts
Melatonin and N-acetyltryptamine could easily
form adducts with sodium ion in the positive
electrospray ionization process. The formation of
sodium adducts [M+Na]+ competed with the
formation of quasi-molecular ions [M+H]+ and
affected the detection sensitivity. Hence, it should
be suppressed. The experiments indicated that
ammonium formate was more effective in sup-
pressing the formation of sodium adducts than
formic acid; whereas formic acid might cause a
low ionization efficiency of the analytes as trifl-
uoroacetic acid (TFA) did in the previous study
[19]. For the subsequent studies, 5% 5 mM ammo-
nium formate (pH 4.0) was used with 95%
CH3CN as the elution buffer for achieving high
detection sensitivity.
Analytical performance
The MRM mode was used for quantitation. Its
specificity for detecting melatonin and N-acetyl-
tryptamine was illustrated by the representative
mass chromatograms in Fig. 7, which showed no
sign of interference from the co-eluting endoge-
nous compounds in the serum matrix.
The recovery studies of melatonin and N-
acetyltryptamine were conducted at three-concen-
tration levels (2.00, 20.0 and 150 ng/ml) and the
results were summarized in Table 2. The absolute
recoveries of melatonin and N-acetyltryptamine
were 68.9–70.5 and 53.2–59.1%, respectively. The
recovery data showed good consistency at all
levels. It is noted that recoveries of analytes de-
creased gradually with a sample injection volume
greater than 50 l (data not shown), which were
probably due to the loading capacity of the ex-
traction column at given concentration levels. In
this work, an injection volume of 10 l was used
for quantitation.
The method developed has excellent intra- and
inter-assay precision for melatonin. As shown in
Table 3, The relative standard deviations of mela-
tonin at four-concentrations for the within-day
(intra-assay) study ranged 0.8–2.0% (n=5) and
the day-to-day (inter-assay) study ranged 1.5–
5.9% (n=3).
A good linear relationship was found between
the peak-area ratios of melatonin to N-acetyl-
tryptamine (the internal standard) versus the con-
centrations of melatonin ranging 0.500–200
ng/ml. Linear regression analysis indicated that
the correlation coefficient (r2) was greater than
0.999, and the regression equation was Y=0.129
X+0.001 with Y as the peak area ratio and X as
the concentration of melatonin.
The measured serum melatonin concentrations
were found to be in good agreement with the
actual concentrations of melatonin prepared by
spiking melatonin in human blank sera. The accu-
racy bias shown in Table 4 ranged from −0.80 to
−5.9% at the four concentrations evaluated.
Table 3
Intra- and inter-assay precision of serum melatonin
Melatonin Inter-assayIntra-assay
(ng/ml) (%CV, n=5) (%CV, n=3)
1.00 2.0 5.9
1.80.805.00
1.51.825.0
2.51.7150
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Table 4
Accuracy of the serum melatonin measurement
Melatonin added (ng/ml) Accuracy bias (%)aMelatonin measured (ng/ml) %CV (n=5)
−5.91.00 2.00.941
5.00 4.95 −1.0 0.80
25.0 −0.8024.8 1.8
−2.7146 1.7150
a Accuracy bias (%)= (measured value−nominal value)/nominal value×100.
The limit of detection defined as the signal-to-
noise ratio of 3 was 0.100 ng/ml for serum mela-
tonin (n=3) and the limit of quantitation defined
as the lowest detectable analyte concentration
which has an accuracy bias of 18% was 0.500
ng/ml for serum melatonin (n=3).
In comparison with the previously reported
atomspheric pressure chemical ionization (APCI)-
MS-MS method 20, it is clearly evident that our
ESI–MS–MS method for serum melatonin has
lower limit of detection and wider linear dynamic
range, are capable of handling larger amount of
sample and higher flow rates.
Applicability to pharmacokinetic studies
According to Dollins et al. [9], melatonin doses
at 1 mg or greater were needed to generate peak
serum melatonin levels that exceeded the normal
range of nocturnal melatonin levels in untreated
people, which corresponded to peak serum mela-
tonin levels 0.500 ng/ml or higher.
The method developed has a limit of quantita-
tion of 0.500 ng/ml with 10-l sample injection,
which is suitable for the pharmacokinetic study of
melatonin at doses greater than 1 mg. It should
also be pointed out that the extraction cartridge
used in this work has concentration capability,
which allows us to injection sample volumes up to
50 l without sacrificing the analyte recoveries.
Therefore, if lower limits of quantitation are de-
sirable, larger sample volumes can be used. Al-
though the method developed has not yet been
tested with clinical samples, its applicability to
serum melatonin has been demonstrated.
Conclusions
A rapid, simple and sensitive analytical method
for the quantitative determination of melatonin in
human serum has been developed and validated.
It employs on-line sample preparation and ESI–
MS–MS detection. Serum samples can be directly
injected into the system and be analyzed within 9
min. The method has wide linear dynamic range,
low limit of quantitation, high specificity and
sensitivity, as well as excellent reproducibility and
accuracy. It may be used for the pharmacokinetic
study of melatonin in human sera.
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